Secnidazole for treatment of bacterial vaginosis: a systematic review
Abstract Background Bacterial vaginosis (BV) is one of the common vaginal infections among childbearing women. The usual treatment for BV is metronidazole; hence 30% of women have recurrence within 60 to 90 days after treatment. There are some studies which assessed the effect of secnidazole on BV....
Saved in:
Main Authors: | Mohamed A. Abd El Aziz (Author), Foruzan Sharifipour (Author), Parvin Abedi (Author), Shayesteh Jahanfar (Author), Helen Marie Judge (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secnidazol`s effectiveness for the bacterial vaginosis treatment
by: Olga F. Serova, et al.
Published: (2023) -
Therapeutic capabilities of secnidazole in the treatment of bacterial vaginosis
by: Yu.E. Dobrokhotova, et al.
Published: (2022) -
The effect of hyoscine n- butylbromide on labor progress: A systematic review
by: Zaynab Mohaghegh, et al.
Published: (2020) -
In vitro metabolic profile and drug‐drug interaction assessment of secnidazole, a high‐dose 5‐nitroimidazole antibiotic for the treatment of bacterial vaginosis
by: Helen S. Pentikis, et al.
Published: (2020) -
Treatment of Bacterial Vaginosis: A Multicenter, Double-Blind, Double-Dummy, Randomised Phase III Study Comparing Secnidazole and Metronidazole
by: Jean-Marc Bohbot, et al.
Published: (2010)